McIlrath & Eck’s Celgene Corp CELG Stock Holding History

McIlrath & Eck’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-488	Closed	-$48K	–	682
2019 Q3	$48K	Buy	488 +350	+254%	+$33.3K	0.03%	127
2019 Q2	$13K	Hold	138	–	–	0.01%	286
2019 Q1	$13K	Buy	138 +24	+21%	+$2.1K	0.01%	286
2018 Q4	$7K	Hold	114	–	–	﹤0.01%	327
2018 Q3	$10K	Hold	114	–	–	0.01%	295
2018 Q2	$9K	Hold	114	–	–	0.01%	298
2018 Q1	$10K	Hold	114	–	–	0.01%	270
2017 Q4	$12K	Buy	+114	New	+$12.9K	0.01%	258

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

McIlrath & Eck's CELG Position: Q4 2019 in Review

McIlrath & Eck sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 488 shares — an estimated $48K sold.

McIlrath & Eck first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $48K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

McIlrath & Eck reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
McIlrath & Eck sold 488 Celgene Corp shares in Q4 2019, an estimated $48K.
McIlrath & Eck first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
McIlrath & Eck's Celgene Corp position peaked at $48K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on McIlrath & Eck's 13F filing for Q4 2019, filed 11 Feb 2020.